1,730
Views
4
CrossRef citations to date
0
Altmetric
Brief Report

Direct bisulphite conversion of cervical samples for DNA methylation analysis

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1173-1179 | Received 02 Mar 2021, Accepted 08 Oct 2021, Published online: 27 Oct 2021

References

  • Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–1953
  • Ronco G, Dillner J, Elfstrom KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524–532.
  • Wentzensen N, Sherman ME, Schiffman M, et al. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol. 2009;112(2):293–299.
  • Kelly H, Benavente Y, Pavon MA, et al. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. Br J Cancer. 2019;121(11):954–965.
  • Steenbergen RD, Snijders PJ, Heideman DA, et al. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14(6):395–405.
  • Bierkens M, Sm W, WN VW, et al. Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection. Int J Cancer. 2012;131(4):E579–585.
  • LMA DS, Berkhof J, Steenbergen RDM, et al. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124- methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up. Int J Cancer. 2018;143(6):1541–1548.
  • Dick S, Kremer WW, LMA DS, et al. Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis. Gynecol Oncol. 2019;154(2):368–373.
  • Vink FJ, Lissenberg-Witte BI, Meijer C, et al. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort. Clin Microbiol Infect. 2021 Jan;27(1):125.e1-125.e6.
  • Bonde J, Floore A, Ejegod D, et al. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary HPV screen positive women; A large European multi-center study. Int J Cancer. 2020.
  • Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23–38.
  • Feng L, Lou J. DNA Methylation Analysis. Methods Mol Biol. 2019;1894:181–227.
  • EZ DNA Methylation(TM) Kit - Instruction manual Version 1.2.6; https://www.zymoresearch.com/collections/ez-DNA-methylation-kits/products/ez-DNA-methylation-kit, Accessed on June 8, 2021
  • QIAsure Methylation Test Instructions for use (handbook) Version 1 (March 2017). https://www.qiagen.com/nl/resources/resourcedetail?id=d4851ddc-405d-4d93-be9a-a343c8576d64&lang=en; Accessed on June 8, 2021.
  • Fast E 96 Bisulfite Conversion Handbook (July 2020) https://www.qiagen.com/us/resources/resourcedetail?id=96b87a18-4894-432a-ae20-6c18dfb9ba20&lang=en; Accessed on June 8, 2021
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–310.
  • Rausch S, Hasinger O, Konig T, et al. An automated high throughput solution for DNA extraction and bisulfite-conversion from high volume liquid biopsy specimens: sample preparation for epigenetic analysis. BMC Res Notes. 2019;12(1):551.
  • Floore A, Hesselink A, Ostrbenk A, et al. Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: results from an international study. J Clin Lab Anal. 2019;33(4):e22854.
  • Arbyn M, Ronco G, Cuzick J, et al. How to evaluate emerging technologies in cervical cancer screening? Int J Cancer. 2009;125(11):2489–2496.
  • Holmes EE, Jung M, Meller S, et al. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine. PLoS One. 2014;9(4):e93933.
  • Ajenifuja KO, Belinson J, Goldstein A, et al. Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2. Infect Agent Cancer. 2020;15(1):61.